Energy And Mining Industry Reports

Reports > Energy And Mining > Selected Report

Global Prostate Cancer Diagnostics Market Report 2018

Single User: $2999
Multiple User: $3999
Enterprise User: $5999


Report Summary:

The prostate is a walnut-sized gland located behind the base of a mans penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Scope of the Report:
This report focuses on the Prostate Cancer Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global average gross margin of Prostate Cancer Diagnostics is in the decreasing trend, from 73.4% in 2012 to 71.6% in 2016. With the situation of global economy and technology, gross margin will be in decreasing trend in the following five years.
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2016 is about 44%.
Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Prostate Cancer Diagnostics is expected to grow at a CAGR of roughly 7.1% over the next five years, will reach 17900 million US$ in 2023, from 11900 million US$ in 2017, according to a new GIR study.

Market Segment by Manufacturers, this report covers
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Tumor Biomarker Tests
Imaging
Biopsy
Other

Market Segment by Applications, can be divided into
age < 55
age 55-75
age > 75

There are 15 Chapters to deeply display the global Prostate Cancer Diagnostics market.
Chapter 1, to describe Prostate Cancer Diagnostics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Prostate Cancer Diagnostics, with sales, revenue, and price of Prostate Cancer Diagnostics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Prostate Cancer Diagnostics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Prostate Cancer Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Prostate Cancer Diagnostics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents

1 Market Overview
1.1 Prostate Cancer Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Tumor Biomarker Tests
1.2.2 Imaging
1.2.3 Biopsy
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 age < 55
1.3.2 age 55-75
1.3.3 age > 75
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genomic Health
2.1.1 Business Overview
2.1.2 Prostate Cancer Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
2.2.1 Business Overview
2.2.2 Prostate Cancer Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 OPKO
2.3.1 Business Overview
2.3.2 Prostate Cancer Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Siemens Healthcare
2.4.1 Business Overview
2.4.2 Prostate Cancer Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 DiaSorin
2.5.1 Business Overview
2.5.2 Prostate Cancer Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 bioMeriux
2.6.1 Business Overview
2.6.2 Prostate Cancer Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 bioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Roche
2.7.1 Business Overview
2.7.2 Prostate Cancer Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 MDx Health
2.8.1 Business Overview
2.8.2 Prostate Cancer Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Beckman Coulter
2.9.1 Business Overview
2.9.2 Prostate Cancer Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Myriad Genetics
2.10.1 Business Overview
2.10.2 Prostate Cancer Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Ambry Genetics
2.11.1 Business Overview
2.11.2 Prostate Cancer Diagnostics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Prostate Cancer Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Prostate Cancer Diagnostics Manufacturer Market Share in 2017
3.3.2 Top 6 Prostate Cancer Diagnostics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Prostate Cancer Diagnostics Market Analysis by Regions
4.1 Global Prostate Cancer Diagnostics Sales, Revenue and Market Share by Regions
4.1.1 Global Prostate Cancer Diagnostics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Regions (2013-2018)
4.2 North America Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
4.3 Europe Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
4.5 South America Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
5 North America Prostate Cancer Diagnostics by Countries
5.1 North America Prostate Cancer Diagnostics Sales, Revenue and Market Share by Countries
5.1.1 North America Prostate Cancer Diagnostics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Prostate Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)
5.2 United States Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
5.3 Canada Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
5.4 Mexico Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
6 Europe Prostate Cancer Diagnostics by Countries
6.1 Europe Prostate Cancer Diagnostics Sales, Revenue and Market Share by Countries
6.1.1 Europe Prostate Cancer Diagnostics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Prostate Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
6.3 UK Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
6.4 France Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
6.5 Russia Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
6.6 Italy Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Prostate Cancer Diagnostics by Countries
7.1 Asia-Pacific Prostate Cancer Diagnostics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Prostate Cancer Diagnostics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Prostate Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)
7.2 China Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
7.3 Japan Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
7.4 Korea Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
7.5 India Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
8 South America Prostate Cancer Diagnostics by Countries
8.1 South America Prostate Cancer Diagnostics Sales, Revenue and Market Share by Countries
8.1.1 South America Prostate Cancer Diagnostics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Prostate Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
8.3 Argentina Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
8.4 Colombia Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Prostate Cancer Diagnostics by Countries
9.1 Middle East and Africa Prostate Cancer Diagnostics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Prostate Cancer Diagnostics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Prostate Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
9.3 UAE Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
9.4 Egypt Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
9.5 Nigeria Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
9.6 South Africa Prostate Cancer Diagnostics Sales and Growth Rate (2013-2018)
10 Global Prostate Cancer Diagnostics Market Segment by Type
10.1 Global Prostate Cancer Diagnostics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
10.1.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Tumor Biomarker Tests Sales Growth and Price
10.2.1 Global Tumor Biomarker Tests Sales Growth (2013-2018)
10.2.2 Global Tumor Biomarker Tests Price (2013-2018)
10.3 Imaging Sales Growth and Price
10.3.1 Global Imaging Sales Growth (2013-2018)
10.3.2 Global Imaging Price (2013-2018)
10.4 Biopsy Sales Growth and Price
10.4.1 Global Biopsy Sales Growth (2013-2018)
10.4.2 Global Biopsy Price (2013-2018)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2013-2018)
10.5.2 Global Other Price (2013-2018)
11 Global Prostate Cancer Diagnostics Market Segment by Application
11.1 Global Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
11.2 age < 55 Sales Growth (2013-2018)
11.3 age 55-75 Sales Growth (2013-2018)
11.4 age > 75 Sales Growth (2013-2018)
12 Prostate Cancer Diagnostics Market Forecast (2018-2023)
12.1 Global Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2023)
12.2 Prostate Cancer Diagnostics Market Forecast by Regions (2018-2023)
12.2.1 North America Prostate Cancer Diagnostics Market Forecast (2018-2023)
12.2.2 Europe Prostate Cancer Diagnostics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Prostate Cancer Diagnostics Market Forecast (2018-2023)
12.2.4 South America Prostate Cancer Diagnostics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Prostate Cancer Diagnostics Market Forecast (2018-2023)
12.3 Prostate Cancer Diagnostics Market Forecast by Type (2018-2023)
12.3.1 Global Prostate Cancer Diagnostics Sales Forecast by Type (2018-2023)
12.3.2 Global Prostate Cancer Diagnostics Market Share Forecast by Type (2018-2023)
12.4 Prostate Cancer Diagnostics Market Forecast by Application (2018-2023)
12.4.1 Global Prostate Cancer Diagnostics Sales Forecast by Application (2018-2023)
12.4.2 Global Prostate Cancer Diagnostics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 40260

Category: 17

Published date: 2018-06-20 19:55:05

Number of Pages: 131

Publisher Name: GIR

Over all Rating: 87 % (Average of Ratings provided by clients)